Amedeo Smart

Free Medical Literature Service


 

Amedeo

Sexually Transmitted Diseases

  Free Subscription

Articles published in
Cancer
    March 2024
  1. CONTRERA KJ, Patel MR, Burtness B, Mehra R, et al
    The role of surgery and deescalation for HPV-related oropharyngeal cancer.
    Cancer. 2024 Mar 18. doi: 10.1002/cncr.35287.
    >> Share

    December 2023

  2. Researchers identify two new subtypes of HPV-associated head and neck cancers.
    Cancer. 2023;129:3842.
    >> Share

  3. NAZHA B, Zhuang T, Wu S, Brown JT, et al
    Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
    Cancer. 2023;129:3884-3893.
    >> Share

    November 2023

  4. HPV testing in older women may improve cervical cancer prevention.
    Cancer. 2023;129:3518.
    >> Share

    June 2023
  5. FRANCO EL
    The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
    Cancer. 2023 Jun 22. doi: 10.1002/cncr.34899.
    >> Share

    May 2023
  6. RAMKUMAR SP, Simpson MC, Adjei Boakye E, Bukatko AR, et al
    High-risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma.
    Cancer. 2023;129:1372-1383.
    >> Share

    April 2023
  7. AREVALO M, Brownstein NC, Whiting J, Vadaparampil ST, et al
    Factors related to human papillomavirus vaccine uptake and intentions among adults aged 18-26 and 27-45 years in the United States: A cross-sectional study.
    Cancer. 2023;129:1237-1252.
    >> Share

  8. D'SOUZA G, Tewari SR, Troy T, Waterboer T, et al
    Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
    Cancer. 2023 Apr 9. doi: 10.1002/cncr.34783.
    >> Share

    February 2023
  9. CHERVEN B, Klosky JL, Keith KE, Hudson MM, et al
    Reasons for refusal of the human papillomavirus vaccine among young cancer survivors.
    Cancer. 2023;129:614-623.
    >> Share

  10. QUAN DL, Grauer JS, Sunkara PR, Cramer JD, et al
    Surgical salvage of human papillomavirus-positive oropharyngeal cancer: Secondary analysis of a randomized controlled trial.
    Cancer. 2023;129:376-384.
    >> Share

    November 2022
  11. KOYUNCU CF, Nag R, Lu C, Corredor G, et al
    Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Cancer. 2022;128:3831-3842.
    >> Share

    October 2022
  12. RIMEL BJ, Kunos CA, Macioce N, Temkin SM, et al
    Current gaps and opportunities in screening, prevention, and treatment of cervical cancer.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34487.
    >> Share

  13. MARKOVINA S, Rendle KA, Cohen AC, Kuroki LM, et al
    Improving cervical cancer survival-A multifaceted strategy to sustain progress for this global problem.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34485.
    >> Share

    June 2022
  14. O'BOYLE CJ, Siravegna G, Varmeh S, Queenan N, et al
    Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2022;128:2193-2204.
    >> Share

    May 2022
  15. HUANG SH, Jacinto JCK, O'Sullivan B, Su J, et al
    Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
    Cancer. 2022 May 19. doi: 10.1002/cncr.34266.
    >> Share

    April 2022
  16. O'ROURKE K
    Better HPV vaccination and cervical cancer screening needed.
    Cancer. 2022;128:1559.
    >> Share

    February 2022
  17. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    >> Share

  18. O'ROURKE K
    Cutaneous beta-HPV may predict cutaneous squamous cell carcinoma.
    Cancer. 2022;128:646.
    >> Share

  19. SCOTT-WITTENBORN N, D'Souza G, Tewari S, Rooper L, et al
    Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.
    Cancer. 2022 Feb 8. doi: 10.1002/cncr.34124.
    >> Share

    January 2022
  20. HENDERSON TO, Fowler BW, Hamann HA, Nathan PC, et al
    Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
    Cancer. 2022;128:373-382.
    >> Share

    December 2021
  21. WOTMAN MT, Miles BA, Bakst RL, Posner MR, et al
    A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2021;127:4330-4338.
    >> Share

    November 2021
  22. DESAI S, Zhu MJ, Lapidos-Salaiz I
    Cervical cancer prevention: Human papillomavirus testing as primary screening.
    Cancer. 2021 Nov 12. doi: 10.1002/cncr.34006.
    >> Share

    October 2021
  23. BRANDT HM, Kepka D, Kirchhoff AC, Daniel CL, et al
    Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors.
    Cancer. 2021 Oct 4. doi: 10.1002/cncr.33920.
    >> Share

  24. NIERENGARTEN MB
    Study shows a decrease in cervical cancer but a rise in other human papillomavirus-related cancers.
    Cancer. 2021;127:3499.
    >> Share

  25. PINATTI LM, Gu W, Wang Y, Elhossiny A, et al
    SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Cancer. 2021;127:3531-3540.
    >> Share

    September 2021
  26. WU J, Xiao F, Zheng Y, Lin Y, et al
    Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
    Cancer. 2021;127:3172-3182.
    >> Share

  27. RYAN WR, Xu MJ, Ochoa E, Plonowska-Hirschfeld KA, et al
    Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients.
    Cancer. 2021;127:3092-3106.
    >> Share

    August 2021
  28. SCHRANK TP, Lenze N, Landess LP, Hoyle A, et al
    Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Cancer. 2021;127:2788-2800.
    >> Share

    July 2021
  29. MIX JM, Saraiya M, Thompson TD, Querec TD, et al
    Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States.
    Cancer. 2021 Jul 21. doi: 10.1002/cncr.33582.
    >> Share

  30. WHITMARSH A, Pring M, Thomas SJ, Waylen A, et al
    Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
    Cancer. 2021;127:2442-2452.
    >> Share

    June 2021
  31. FU TS, Scheffler P, Forner D, Noel CW, et al
    A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33653.
    >> Share

    May 2021
  32. WEISS JM
    Surgery alone for transorally resected human papillomavirus-driven head and neck cancer-Can we de-intensify adjuvant therapy to 0 Gy and 0 mg/m(2) ?
    Cancer. 2021 May 6. doi: 10.1002/cncr.33610.
    >> Share

    April 2021
  33. PRINTZ C
    Lower Cervical Cancer Risk Associated With HPV Vaccine.
    Cancer. 2021;127:1171.
    >> Share

  34. PRINTZ C
    Updated American Cancer Society HPV Vaccine Guideline Seeks to Reinforce Key Messages: New recommendations emphasize the importance of routinely offering the vaccine at the ages of 9 to 12 years.
    Cancer. 2021;127:1169-1170.
    >> Share

  35. DRAKE VE, Fakhry C, Windon MJ, Stewart CM, et al
    Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
    Cancer. 2021;127:1029-1038.
    >> Share

    March 2021
  36. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    >> Share

    February 2021
  37. SHEWALE JB, Pickard RKL, Xiao W, Jiang B, et al
    Independent association of marijuana use and poor oral hygiene with HPV-negative but not HPV-positive head and neck squamous cell carcinomas.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33440.
    >> Share

  38. HO AS, Luu M, Kim S, Tighiouart M, et al
    Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33414.
    >> Share

    April 2020
  39. BROTHERTON JML, Sundstrom K
    More evidence suggesting that 1-dose human papillomavirus vaccination may be effective.
    Cancer. 2020;126:1602-1604.
    >> Share

  40. RODRIGUEZ AM, Zeybek B, Vaughn M, Westra J, et al
    Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Cancer. 2020;126:1656-1667.
    >> Share

  41. BIGELOW EO, Blackford AL, Eytan DF, Eisele DW, et al
    Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls.
    Cancer. 2020;126:1793-1803.
    >> Share

  42. FULLERTON ZH, Butler SS, Mahal BA, Muralidhar V, et al
    Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
    Cancer. 2020;126:1424-1433.
    >> Share

  43. OLIVER JR, Lieberman SM, Tam MM, Liu CZ, et al
    Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma.
    Cancer. 2020;126:1413-1423.
    >> Share

    March 2020
  44. ZHAN KY, Puram SV, Li MM, Silverman DA, et al
    National treatment trends in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2020;126:1295-1305.
    >> Share

    January 2020
  45. GAISA MM, Liu Y, Deshmukh AA, Stone KL, et al
    Electrocautery ablation of anal high-grade squamous intraepithelial lesions: Effectiveness and key factors associated with outcomes.
    Cancer. 2020 Jan 24. doi: 10.1002/cncr.32581.
    >> Share

  46. FREITAG J, Wald T, Kuhnt T, Gradistanac T, et al
    Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2020;126:1856-1872.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016